Literature DB >> 23025406

Molecular modeling study bioactive natural product of khellin analogues as a novel potential pharmacophore of EGFR inhibitors.

Abdel-Sattar S Hamad Elgazwy1, Mastoura M Edrees, Nasser S M Ismail.   

Abstract

Khelline is naturally occurring furochromone exhibited significant Epidermal Growth Factor Receptor (EGFR) inhibitory activity. The newly synthesized compounds 2-5 displayed the most potent EGFR inhibitory activity on MCF-7 and HeLa. In vitro study against 59 different human tumour cell lines derived from nine cancer type in NCI (USA), which was presented and documented. Molecular docking simulation was performed to position compounds 1-5 into the EGFR active site to determine the probable binding mode.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23025406     DOI: 10.3109/14756366.2012.719504

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  4 in total

1.  A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer.

Authors:  Fen Liu; Zongcheng Yang; Lixin Zheng; Wei Shao; Xiujie Cui; Yue Wang; Jihui Jia; Yue Fu
Journal:  Front Oncol       Date:  2021-06-14       Impact factor: 6.244

2.  Modulation of Drug Resistance by Furanochromones in NorA Overexpressing Staphylococcus Aureus.

Authors:  Damara F Rodrigues; Nathalie H P B Borges; Carlos Emídio S Nogueira; Josean F Tavares; Daniel Dias Rufino Arcanjo; Humberto M Barreto; José P Siqueira-Junior
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-17       Impact factor: 2.650

3.  Synthesis of New Furothiazolo Pyrimido Quinazolinones from Visnagenone or Khellinone and Antimicrobial Activity.

Authors:  Ameen Ali Abu-Hashem
Journal:  Molecules       Date:  2018-10-27       Impact factor: 4.411

Review 4.  From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease.

Authors:  Jazmín Alarcón-Espósito; Michael Mallea; Julio Rodríguez-Lavado
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.